Aurora Therapeutics has emerged from stealth with $16 million in funding from Menlo Ventures to expand the potential of gene ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

The startup aims to create a platform for treating extremely rare genetic mutations, armed with CRISPR advances and new regulatory pathways.

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...

In a landscape where precision is paramount, the base editing market is emerging as a cornerstone of modern biotechnology, ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

The most-watched telecasts of 2025 include the Super Bowl and Oscars, as well as 'Tracker,' '60 Minutes,' 'Dancing With the ...

The article 🌱 Patch AM: Why a Berkeley biologist just won $400,000 for bold CRISPR research appeared first on Berkeley Patch. Hey hey Berkeley! Your one-stop source for local news is here. Continue ...